GS 164

structure in first source

Also Known As:

GS-164

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 01/01/1997 - "Although the cytotoxicity of GS-164 against human tumor cells was 1000-fold lower than that of Taxol and GS-164 was one-tenth as active as Taxol in vitro, these findings pave the way for synthesizing clinically useful anticancer agents using GS-164 as a lead compound."

1.	Paclitaxel (Taxol)
2.	Antineoplastic Agents (Antineoplastics)